$3.91
-0.01-0.26%
最終更新: Oct 9, 3:59 PM
$4.03
0.112.81%
Benzinga
Benzinga
Benzinga
日曜日, 10 11
Benzinga
© 2026 Benzinga | All Rights Reserved
BriaCell Therapeutics (BCTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | FY '21 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | — | $-4.84 | $-3.28 | $-3.28 | — |
| Actual | $-0.99 | $-2.58 | $-4.35 | $-4.81 | $-13.50 |
| Surprise | — | +46.7% | -32.6% | -46.7% | — |
| Revenue | |||||
| Estimate | — | $840000 | $2.1M | $2.1M | — |
| Actual | $0 | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Mar 10, 2026 | $-2.58 | $-4.84 | 46.7 % |
| Q1 | Dec 11, 2025 | $-4.35 | $-3.28 | -32.6 % |
| Q4 | Oct 16, 2025 | $-4.81 | $-3.28 | -46.7 % |
| Q1 | Dec 16, 2024 | $-33.00 | $-45.00 | 26.7 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Mar 10, 2026 | $0 | $840.00K | -100.0 % |
| Q1 | Dec 11, 2025 | $0 | $2.10M | -100.0 % |
| Q4 | Oct 16, 2025 | $0 | $2.10M | -100.0 % |